ChiCTR2000032016 版本V1.5 版本创建时间2020/04/17 22:24:56 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000032016 

最近更新日期:

Date of Last Refreshed on:

2020-04-17 22:23:34 

注册时间:

Date of Registration:

2020-04-17 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

骨科手术导航系统辅助膝关节置换手术的探索性研究

Public title:

An exploratory study on the application of navigation system to assist knee replacement in orthopaedic surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

骨科手术导航系统辅助膝关节置换手术的探索性研究

Scientific title:

An exploratory study on the application of navigation system to assist knee replacement in orthopaedic surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

夏润之 

研究负责人:

李慧武 

Applicant:

Runzhi Xia 

Study leader:

Huiwu Li 

申请注册联系人电话:

Applicant telephone:

+86 13166015517

研究负责人电话:

Study leader's
telephone:

+86 13122649860

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

734756748@qq.com

研究负责人电子邮件:

Study leader's E-mail:

huiwu1223@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市制造局路639号

研究负责人通讯地址:

上海市制造局路639号

Applicant address:

639 Zhizaoju Road, Shanghai, China

Study leader's address:

639 Zhizaoju Road, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海交通大学附属第九人民医院

Applicant's institution:

The Ninth People's Hospital Affiliated to Shanghai Jiaotong University

研究负责人所在单位:

上海交通大学附属第九人民医院

Affiliation of the Leader:

The Ninth People's Hospital Affiliated to Shanghai Jiaotong University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

SH9H-2019-T212-2

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海交通大学医学院附属第九人民医院转化医学伦理审查专委会

Name of the ethic committee:

Transformation Medical Ethics Review Committee of the Ninth People's Hospital Affiliated to Shanghai Jiaotong University

伦理委员会批准日期:

Date of approved by ethic committee:

2019-11-11 00:00:00

伦理委员会联系人:

甄红

Contact Name of the ethic committee:

Hong Zhen

伦理委员会联系地址:

上海市制造局路639号

Contact Address of the ethic committee:

639 Zhizaoju Road, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海交通大学附属第九人民医院

Primary sponsor:

The Ninth People's Hospital Affiliated to Shanghai Jiaotong University

研究实施负责(组长)单位地址:

上海市制造局路639号

Primary sponsor's address:

639 Zhizaoju Road, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市第九人民医院

具体地址:

黄浦区制造局路639号

Institution
hospital:

Shanghai Ninth People's Hospital

Address:

639 Zhizaoju Road, Huangpu District

经费或物资来源:

国家重点研发计划2017YFC0110700

Source(s) of funding:

National KeyResearch & Development Project 2017YFC0110700

研究疾病:

膝关节骨关节炎  

Target disease:

Knee osteoarthritis

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

单臂 

Study design:

Single arm 

研究目的:

探索骨科手术导航系统辅助膝关节置换临床应用的安全性和有效性。  

Objectives of Study:

To explore the safety and effectiveness of orthopedic surgery navigation system in clinical application of knee arthroplasty.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

受试者必须符合下列所有入选标准:
(1) 21 周岁≤实际年龄<75 周岁;
(2) 能够进行外科手术并能够配合完成后续随访,有良好的依从性;
(3) 需进行单侧膝关节置换;
(4) 有功能性良好的韧带;
(5) 自愿参加本试验并书面签署知情同意书。

Inclusion criteria

Subjects must meet all of the following inclusion criteria:
1. Subjects with 21 years old <= actual age < 75 years old;
2. Patients who are able to perform surgery and follow-up with good compliance;
3. Patients who need unilateral knee replacement;
4. Subjects with good functional ligaments;
5. The subjects who voluntarily participate in the test and are willing to sign the informed consent in writing.

排除标准:

受试者不能符合下列任何一项排除标准:
(1) 同侧下肢主要关节(髋和膝关节)曾经进行置换术的受试者;
(2) 近 3 个月内参与过其他研究性药物或器械临床研究者;
(3) 固定性屈曲挛缩或内翻畸形大于 15 °;
(4) 存在髋关节或踝关节的强直畸形;
(5) 已知或者怀疑对聚乙烯、钛、钴、铬或者含铁元素材料过敏的;
(6) 受试者呈免疫抑制状态,患有自身免疫疾病或者免疫抑制障碍;
(7) 受试者由于疾病(如肿瘤、重度骨质疏松、或者代谢性骨病等)导致无法支 撑和/或固定假体;
(8) 不能理解参与研究的要求,或不能完成研究随访计划;
(9) 其他研究者认为不适合本临床研究的情形。

Exclusion criteria:

Subjects could not meet any of the following exclusion criteria:
1. Subjects whose major joints (hip and knee joints) of the same side of the lower limb have been replaced;
2. Subjects who have participated in clinical research of other investigational drugs or devices in the past 3 months;
3. Patients with fixed flexion contracture or varus greater than 15 degrees;
4. Patients with ankylosis of hip or ankle;
5. Patients who are known or suspected to be allergic to polyethylene, titanium, cobalt, chromium or ferrous materials;
6. Patients with immunosuppressive state, autoimmune disease or immunosuppressive disorder;
7. Subjects who are unable to support and / or fix the prosthesis due to diseases (such as tumor, severe osteoporosis, or metabolic osteopathy, etc.);
8. Subjects who could not understand the requirements of participating in the study or could not complete the follow-up plan of the study;
9. Other researchers think it is not suitable for this clinical study.

研究实施时间:

Study execute time:

From 2020-04-30 00:00:00 To 2020-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-04-30 00:00:00 To 2020-11-30 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

8

Group:

experimental group

Sample size:

干预措施:

使用骨科手术导航系统辅助膝关节置换手术

干预措施代码:

Intervention:

Orthopedic surgical navigation system was used to assist knee replacement

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市第九人民医院 

单位级别:

三甲 

Institution
hospital:

Shanghai Ninth People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

不良事件发生情况

指标类型:

主要指标

Outcome:

The occurrence of adverse events

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

下肢力线偏移角

指标类型:

主要指标

Outcome:

Deviation Angle of limb alignment

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

WOMAC评分

指标类型:

主要指标

Outcome:

the Western Ontario and McMaster Universities Osteoarthritis Index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

KSS评分

指标类型:

主要指标

Outcome:

Knee Society Score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 21 years
最大 Max age 74 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

本实验为单臂研究,无需随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

This experiment is a single-arm study without random grouping.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验结束后6个月,文章发表后

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

6 months after the end of the trial, it will be published in the form of articles

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例报告表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2020-04-17 21:28:41